Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
[Review on domestic published papers regarding the acute disseminated encephalomyelitis and its relations with rabies vaccination].
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
Vowel Acoustics in Parkinson's disease and Multiple Sclerosis: Comparison of Clear, Loud and Slow Speaking Conditions.
Clinical and pathological features of acute optic neuritis in Chinese patients.
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review.
Progress of mesenchymal stem cell therapy for neural and retinal diseases.
Clinical utility of glatiramer acetate in the management of relapse frequency in multiple sclerosis.
The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.
Kindlin-3 regulates integrin activation and adhesion reinforcement of effector T cells.
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Prospective Evaluation of Laparoscopic Assisted Cystectomy and Ileal Conduit in Advanced Multiple Sclerosis.
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS.
The earlier, the smaller, the better for natalizumab-associated PML: In MRI vigilance veritas?
Childhood transverse myelitis and its mimics.
Estrogen inhibits estrogen receptor(ER) α-mediated rho-kinase expression in experimental autoimmune encephalomyelitis rats.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation.
Inhibitory effect of IL-17 on neural stem cell proliferation and neural cell differentiation.
Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
[2012: news in neurology].
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Pages
« first
‹ previous
…
268
269
270
271
272
273
274
275
276
…
next ›
last »